Phase Forward, Inc. (NASDAQ:PFWD)

CAPS Rating: 2 out of 5

A provider of integrated enterprise-level software products, services and hosted solutions for use in its customers' global clinical trial and drug safety monitoring activities.

Recs

2
Player Avatar GabrielLerman (< 20) Submitted: 3/27/2009 3:23:18 PM : Outperform Start Price: $12.86 PFWD Score: -30.81

Having used Phase Forward's products and compared them to some of the offerings from their competition, they make a great product.

The Pharma industry could be shifting a little but I think it could help PFWD. Regulatory agencies are requiring more data before approving new treatments and PFWD is positioned well to help Pharma companies collect and analyze these large amounts of data.

Featured Broker Partners


Advertisement